Cholinergic deficiency is a hallmark neurotransmitter abnormality in Alzheimer's disease (AD) that has traditionally been addressed with cholinesterase inhibitors. The gene discussed is BCHE; the disease is early-onset autosomal dominant Alzheimer disease.